In a move to make public health safer and convenient, the Indian government has banned the usage of several drugs including various cocktail or combination drugs.Along with this, 34 multivitamins …
New Delhi: A total of 24 blockbuster drugs, with global sales worth $251 billion, have lost or are set to lose their patents in the US by 2030, which could …
Marksans, whose product portfolio includes therapeutic segments of cardiovascular, central nervous system, antidiabetic, pain management, gastroenterology and anti-allergy drugs and whose market capitalisation stood at Rs 5,299.75 crore in August last …
New Delhi: A new report by a network of multinational pharma companies and a leading consulting firm has said that the Indian pharmaceutical market should aim to achieve a size …